S88 Micrornas regulate genome-wide translation in severe asthma bronchial epithelial cells as revealed by frac-seq. (15th November 2017)

• Record Type: Journal Article
• Authors: Martinez-Nunez, RT; Rupani, H; Niranjan, M; Howarth, PH; Sanchez-Elsner, T
• Is Part Of: Thorax. Volume 72(2017)Supplement 3
• Page Start: A54
• Page End: A54
• Publication Date: 2017-11-15
• Subjects: Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2017-210983.94
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Severe asthma represents a significant unmet clinical need and the molecular basis for disease persistence remains inadequately understood. Bronchial epithelial cells, at the interface of environment/tissue, are central to asthma pathogenesis. There is thus a need to evaluate genome-wide changes between health and asthma to better understand the molecular mechanisms underlying disease. The vast majority of genome-wide measurements have focused on determining changes at the DNA or mRNA levels, with little attention paid to how and which mRNAs are actually translated into protein. This may not disclose changes happening at the protein level, since mRNA and protein expression correlate poorly. To determine translation and its regulation in bronchial epithelial cells in severe asthma patients we analysed paired genome-wide expression of transcriptional (cytoplasmic) and translational (polyribosome-bound) mRNA levels employing Frac-seq (subcellular fractionation and RNA-sequencing) in primary bronchoepithelium in health and severe asthma patients. We also integrated those data with genome-wide profiling of microRNAs to understand their role in gene expression and impact on the pathophysiology of severe asthma bronchial epithelium. We found both genes (=all isoforms of a gene) and mRNA isoforms differentially expressed in severe asthma airways cells, with dysregulated transcriptional mRNA levels (194 genes) showing little overlap with dysregulated translational mRNA (243 genes) expression. We determined novel inflammatory and remodelling pathophysiological mechanisms disclosed solely by polyribosome-bound mRNAs, centred in epithelium remodelling and repair pathways. We also reveal six dysregulated microRNAs accounting for ∼90% of all cellular microRNA targeting, displaying preferential targeting of ∼50% of mRNAs undergoing translation in severe asthma airways cells. Thus, microRNAs in human severe asthma are major regulators of translation in airways epithelium and offer potential as future therapeutic targets.